Veracyte Overview
Veracyte Target Price
Analysts' 12-month price predictions for VCYT.
Get informed when a big investor buys or sells
+ FollowShare Price
$53.79
Average Target Price
$47.00
12.6% downside
12.6% downside4 analysts in the last 4 months
High: $57 | Low: $37
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-01 | NeedhamMike Matson | $57 |  6% upside |  |
| 2026-05-06 | UBS | $52 | 3.3% downside | |
| 2026-05-06 | Canaccord GenuityKyle Mikson | $42 | 21.9% downside | |
| 2026-03-05 | Morgan StanleyKallum Titchmarsh | $37 | 31.2% downside | |
| 2026-01-05 | GuggenheimSubbu Nambi | $50 | 7% downside | |
| 2025-12-01 | Morgan Stanley | $48 | 10.8% downside | |
| 2025-11-05 | UBSLu Li | $48 | 10.8% downside | |
| 2025-11-05 | Canaccord GenuityKyle Mikson | $43 | 20.1% downside | |
| 2025-10-20 | Canaccord GenuityKyle Mikson | $40 | 25.6% downside | |
| 2025-08-08 | Morgan StanleyTejas Savant | $28 | 47.9% downside | |
| 2024-11-07 | NeedhamMike Matson | $44 | 18.2% downside | |
| 2024-08-12 | Morgan StanleyTejas Savant | $26 | 51.7% downside | |
| 2022-05-04 | Morgan Stanley | $23 | 57.2% downside | |
| 2022-05-04 | Needham | $26 | 51.7% downside | |